MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 321 to 340 of 166,322 approvalsPage 17 of 8317

Alendronate Sodium Tablets

Approval Number: 国药准字H20254214
Registration: May 20, 2025

Tolvaptan Orally Disintegrating Tablets

Approval Number: 国药准字H20254195
Registration: May 20, 2025

Cobamamide Capsules

Approval Number: 国药准字H20254196
Registration: May 20, 2025

Lornoxicam for Injection

Approval Number: 国药准字H20254238
Registration: May 20, 2025

Labetalol Hydrochloride Injection

Approval Number: 国药准字H20254191
Registration: May 20, 2025

Torasemide Injection

Approval Number: 国药准字H20254226
Registration: May 20, 2025

Sodium Fluoride [18F] Injection

Approval Number: 国药准字H20254224
Registration: May 20, 2025

Epinephrine Hydrochloride Injection

Approval Number: 国药准字H20254200
Registration: May 20, 2025

Progesterone Soft Capsules

Approval Number: 国药准字H20254199
Registration: May 20, 2025

Tacrolimus Ointment

Approval Number: 国药准字H20254215
Registration: May 20, 2025

Acetylcysteine Granules

Approval Number: 国药准字H20254217
Registration: May 20, 2025

Lemborexant Tablets

Approval Number: 国药准字HJ20250057
Registration: May 20, 2025

Choline Fenofibrate Sustained-release Capsules

Approval Number: 国药准字H20254219
Registration: May 20, 2025

Atosiban Acetate Injection

Approval Number: 国药准字H20254204
Registration: May 20, 2025

Tolvaptan Orally Disintegrating Tablets

Approval Number: 国药准字H20254194
Registration: May 20, 2025

Atosiban Acetate Injection

Approval Number: 国药准字H20254203
Registration: May 20, 2025

Glecirasib Citrate Tablets

Approval Number: 国药准字H20250020
Registration: May 20, 2025

Diphenhydramine Hydrochloride Tablets

Approval Number: 国药准字H20254197
Registration: May 20, 2025

Norepinephrine Bitartrate Injection

Approval Number: 国药准字H20254192
Registration: May 20, 2025

Eldecalcitol Soft Capsules

Approval Number: 国药准字H20254209
Registration: May 20, 2025
广东江正药业有限公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.